A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia
Conditions:   Endometrial Hyperplasia;   Grade 1 Endometrial Cancer Interventions:   Behavioral: Telemedicine behavioral weight intervention;   Drug: Progestin;   Behavioral: Enhanced usual care;   Drug: Levonorgestrel-releasing IUD. Sponsor:   Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2023 Category: Research Source Type: clinical trials